Prostaglandin E2-EP4 Signaling at the Gut-Immune-Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance
{{output}}
Despite advances in dietary and pharmacologic therapies, obesity rates continue to escalate globally. Emerging evidence implicates the gut-immune interface as a key determinant of metabolic dysfunction. This review highlights the prostaglandin E2 (PGE2) EP4 si... ...
